Investing in Merck (NYSE:MRK) three years ago would have delivered you a 43% gain [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
Merck shareholders lost 3.9% over the last year, including dividends, while the broader market gained around 24%, but longer-term investors have made 6% each year over five years. Was this helpful? Yes No What is Merck's total shareholder return (TSR) over the last three years, and how does it compare to its share price return? Merck's TSR is 43% for the last 3 years, which exceeds its share price return, boosted by the dividends paid by the company. Was this helpful? Yes No What would have been the return on investment if I had invested in Merck (NYSE:MRK) three years ago? Investing in Merck (NYSE:MRK) three years ago would have delivered a 43% gain, with the share price growing 31% over the same period, outperforming the market. Was this helpful? Yes No How has Merck's earnings per share (EPS) growth compared to its share price growth over the last three years? Merck achieved compound earnings per share growth of 27% per year, which is higher than the
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- More on MRK's HIV-1 Program [Yahoo! Finance]Yahoo! Finance
- Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]Yahoo! Finance
- BMO cuts rating on Merck and Biogen, on lack of near term catalyst [Yahoo! Finance]Yahoo! Finance
- Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals [Yahoo! Finance]Yahoo! Finance
- Merck & Co., Inc. (NYSE: MRK) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $105.00 price target on the stock, down previously from $136.00.MarketBeat
MRK
Earnings
- 10/31/24 - Beat
MRK
Sec Filings
- 11/22/24 - Form 8-K
- 11/6/24 - Form 10-Q
- 11/4/24 - Form 25-NSE
- MRK's page on the SEC website